Clinical Trials Browser

Premenopausal Breast Cancer × Leuprolide × Clear all

NCT02990845 2023-02-22

PEER

Phase 1/2 Terminated

Premenopausal Breast Cancer

NCT03209518 2019-11-01

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

312 enrolled 17 charts

Premenopausal Breast Cancer